Richard F Borch

This inventor holds 25 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Compositions. Top assignees: Purdue Research Foundation, Research Corporation Technologies, Inc., University of Rochester. Active years: 1984-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard F Borch. Retrieved from https://idiyas.com/inventor/richard-f-borch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 25

% Patents Active = 88.0

CIPO Patents = 2

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.2

ph-index = 10

Forward Citations = 788(Granted Patents)

Location History:

Minneapolis, MN (US) (1984)
Pittsford, NY (US) (1986 - 1999)
Lafayette, IN (US) (2003 - 2018)
Lakewood, CO (US) (2018)

Company Filing History:

7 out of 2,781

Purdue Research Foundation

patents

5 out of 366

Research Corporation Technologies, Inc.

patents

5 out of 994

University of Rochester

patents

4. 3 out of 2,369

Regents of the University of Minnesota

patents

5. 3 out of 37

Terrapin Technologies, Inc.

University of New York

patents

Years Active: 1984-2018

Loading Chart...

Areas of Expertise:

Immunogenic Compositions

Phosphoramide Compounds

Quinone Derivatives

Prodrugs

Antitumor Agents

Bone Marrow Stimulation

Dithiocarbamates

Glutathione Analogs

Cyclophosphamide Analogs

Myelosuppression

Dosage Units

Platinum Compounds

25 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10159750 - Immunogenic compositions and reagents for preparing (2018-12-25),

2. 10010616 - Immunogenic compositions and reagents for preparing (2018-07-03),

3. 9089605 - Quinone derivatives, pharmaceutical compositions, and uses thereof (2015-07-28),

4. 8324378 - Prodrugs and conjugates of prenylation inhibitors (2012-12-04),

5. 7304046 - Phosphoramide compounds (2007-12-04),

6. 7173020 - Phosphoramidates and methods therefor (2007-02-06),

7. 6903081 - Phosphoramidates and methods therefor (2005-06-07),

8. 6656926 - Phosphoramide compounds (2003-12-02),

9. 5955432 - Metabolic effects of certain glutathione analogs (1999-09-21),

10. 5786336 - Target-selective protocols based on mimics (1998-07-28),

11. 5767086 - Bone marrow stimulation by certain glutathione analogs (1998-06-16),

12. 5472956 - Phosphoramidates useful as antitumor agents (1995-12-05),

13. 5403932 - Phosphoramidates useful as antitumor agents (1995-04-04),

14. 5306727 - Phosphoramidates useful as antitumor agents (1994-04-26),

15. 5294430 - Use of dithiocarbamates to treat myelosuppression (1994-03-15),

Sure, here is the article about inventor Richard F Borch:

Title: Spotlight on Richard F Borch: Prolific Inventor from Pittsford, NY

Introduction: Richard F Borch, a man of innovation hailing from Pittsford, NY, has made significant contributions to the field of biotechnology with an impressive number of 17 patents.

Latest Patents: Among his latest patents, two notable ones stand out - "Metabolic effects of certain glutathione analogs" and "Target-selective protocols based on mimics." These patents delve into the realm of potentiation effects in tumor cells, with a focus on selective cytotoxicity and the elevation of GM progenitors in mammalian subjects.

Career Highlights: Richard F Borch has showcased his inventive prowess through his collaborations with prestigious institutions such as the University of Rochester and Research Corporation Technologies, Inc. His work in these settings has led to groundbreaking developments in the field of biotechnology.

Collaborations: Throughout his career, Richard F Borch has collaborated with top-notch professionals in the field. Some of his esteemed coworkers include Therese K Schmalbach and Lawrence M Kauvar, who have contributed significantly to the innovative projects they have worked on together.

Conclusion: Richard F Borch's journey as an inventor is a testament to his dedication to pushing the boundaries of biotechnological advancements. His patents and collaborations have left an indelible mark on the field, paving the way for further innovations in the future.

Profile summary based on public USPTO records.